Rabeprazole Levosulpiride Pellets Manufacturer & Supplier

Anti-Ulcerant (PPIs) • Pellets

Dual-action pellets for GERD with prokinetic support, stabilised for low moisture to protect both actives.

20 mg + 75 mg
  • GradeIP / BP / USP / EP
  • Pack Size25/50 kg
  • CertificationsWHO-GMP • ISO 9001

Product overview

Rabeprazole provides proton pump inhibition, while Levosulpiride provides prokinetic activity. The formulation is designed around controlled particle size, density matching, and appropriate release characteristics to reduce segregation and support reliable capsule or sachet filling. Technical development can include dissolution, compatibility, stability, and formulation assessments according to the intended product specification.

Key characteristics

  • Dual-API pellet system.
  • Controlled density and particle-size distribution.
  • Reduced segregation risk during filling.
  • Suitable for capsule and sachet development.
  • Technical support for formulation optimization and regulatory documentation.

Product specifications

Product
Rabeprazole Levosulpiride Pellets
Form
Pellets
Therapeutic category
Anti-Ulcerant (PPIs)
Strength
20 mg + 75 mg
Grade
IP / BP / USP / EP
Pack size
25/50 kg
Site certifications
WHO-GMP, ISO 9001, ISO 14001

Detailed specifications, COA and technical documentation are shared on request.

Supply and enquiries

Rraynex supplies Rabeprazole Levosulpiride Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.

Send product enquiry Browse all pellets Manufacturing capabilities

Other Rabeprazole products from Rraynex

Frequently asked questions

Enquire Now